You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Microscopic Observation Drug Susceptibility Assay

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in

Completed
Has Results
  • Recurrent Acute Leukemia of Ambiguous Lineage
  • +5 more
  • Chemosensitivity Assay
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 29, 2022

Predictive Assay for Decision Making in Adjuvant Therapy

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Washington, District of Columbia
  • +2 more
Mar 4, 2022

Tuberculosis Trial (Quantiferon Gold, HIV serology, Respiratory secretion culture (sputum or gastric aspirate_)

Not yet recruiting
  • Tuberculosis
  • Quantiferon Gold
  • +5 more
  • (no location specified)
Oct 27, 2023

Renal Cell Carcinoma Trial (Sunitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • (no location specified)
Sep 11, 2023

Aims to Assess Consistency of Clinical Efficacy in Gastric

Recruiting
  • Gastric Cancer
  • Organoids
    • Shenyang, Liaoning, China
      Phase I Clinical Trials Center Of The First Hospital of China Me
    Oct 20, 2023

    Aims to Assess Consistency of Clinical Efficacy in Colorectal

    Recruiting
    • Colorectal Cancer
    • Organoids
      • Shenyang, Liaoning, China
        Phase I Clinical Trials Center Of The First Hospital of China Me
      Oct 20, 2023

      A Novel Multiplex ELISA Assay for Evaluating Microscopic

      Recruiting
      • Bladder Cancer
        • Los Angeles, California
        • +1 more
        Mar 7, 2022

        Neisseria Gonorrhoeae Infection Trial in Seattle (Ciprofloxacin 500 mg)

        Recruiting
        • Neisseria Gonorrhoeae Infection
        • Ciprofloxacin 500 mg
        • Seattle, Washington
          Public Health -- Seattle & King County Sexual Health Clinic
        Mar 9, 2022

        Performance Study of Targeted Sequencing Technology for VAP

        Not yet recruiting
        • VAP - Ventilator Associated Pneumonia
        • tNGS
        • (no location specified)
        Sep 6, 2023

        Oral Premalignant and Malignant Lesions

        Recruiting
        • Oral Cancer
        • Diagnoses Disease
        • exfoliated cytology
        • Cairo, Egypt
          Faculty of Dentistry
        May 18, 2022

        Trial

        Completed
        Has Results
        • Healthy
        • Alinity s Anti-HCV II
        • Saint Paul, Minnesota
        • +3 more
        Sep 16, 2022

        Triage Test for All Oral DR-TB Regimen (TRiAD Study)

        Recruiting
        • Drug Resistant Tuberculosis
        • +3 more
        • Xpert® MTB/XDR
        • Gulele, Addis Ababa, Ethiopia
        • +3 more
        Jun 13, 2022

        Heading in Football: Impact on Neural Blood Biomarkers

        Not yet recruiting
        • Head Injury, Minor
        • +3 more
        • Head impact exposure
        • (no location specified)
        Nov 23, 2023

        Genetic Susceptibility to Severe Infections

        Not yet recruiting
        • Infectious Disease
        • Blood samples drawing
        • Skin biopsy
        • (no location specified)
        Oct 20, 2023

        Autism Spectrum Disorder, ADHD, Neurodevelopmental Disorders Trial in Foggia (repetitive Transcranial Magnetic Stimulation)

        Recruiting
        • Autism Spectrum Disorder
        • +2 more
        • repetitive Transcranial Magnetic Stimulation
        • Foggia, Italy
          Neuropsychiatric Unit for Child and Adolescent, at General Hospi
        Sep 29, 2023

        Anesthesia, General, Hemodynamics Trial in Guangzhou (2mg/kg/min, 1mg/kg/min, 0.5mg/kg/min)

        Completed
        • Anesthesia, General
        • Hemodynamics
        • Guangzhou, Guangdong, China
          the Sixth Affiliated Hospital, Sun Yat-sen University
        Nov 6, 2022

        DualDur In Vitro Diagnostic System in Diagnosis of Lyme

        Completed
        • Lyme Borreliosis
        • DualDur dark-field microscopic test
        • +5 more
        • Wien, Austria
        • +7 more
        Feb 27, 2020

        Drug-resistant Focal Seizure Trial (OnabotulinumtoxinA 145 UNT [Botox])

        Not yet recruiting
        • Drug-resistant Focal Seizure
        • OnabotulinumtoxinA 145 UNT [Botox]
        • (no location specified)
        Oct 31, 2022

        ResiduAl Cancer With Liquid Biopsy Evaluation

        Recruiting
        • Bladder Carcinoma
        • +14 more
        • Guardant Reveal
        • Redwood City, California
          Redwood City
        Sep 7, 2022

        Microscopic Colitis Trial (Faecal Microbiota Transplantation)

        Not yet recruiting
        • Microscopic Colitis
        • Faecal Microbiota Transplantation
        • (no location specified)
        Aug 9, 2023

        Knee Osteoarthritis, Degenerative Joint Disease of Knee Trial in Santa Monica (Embozene MicroSpheres)

        Not yet recruiting
        • Knee Osteoarthritis
        • Degenerative Joint Disease of Knee
        • Embozene MicroSpheres
        • Santa Monica, California
          UCLA Santa Monica Hospital
        Aug 24, 2022

        Infections and Infection Susceptibility

        Recruiting
        • Immune Deficiencies
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 25, 2023

          Accuracy Evaluation of the IdentiClone Dx IGH Assay

          Not yet recruiting
          • B-Cell Lymphoproliferative Disorder
          • IdentiClone Dx IGH (IC IGH Dx) Assay
          • San Diego, California
          • +2 more
          Oct 30, 2023

          Tuberculosis, Multidrug-Resistant Trial in Cape Town (Targeted sequencing using the GenoScreen Deeplex assay)

          Not yet recruiting
          • Tuberculosis, Multidrug-Resistant
          • Targeted sequencing using the GenoScreen Deeplex assay
          • Cape Town, Western Cape, South Africa
            University of Cape Town
          Sep 28, 2021

          Therapeutic Monitoring of Infliximab and Adalimumab

          Recruiting
          • Inflammatory Bowel Diseases
          • Trieste, Italy
            IRCCS Burlo Garofolo
          Sep 5, 2023